Switch View
© BusinessWire
27.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
U.S. FDA Approves Updated Indication for WINREVAIR™ (sotatercept-csrk) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension) Based on Phase 3 ZENITH Study
News Preview
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an update to the U.S. product label based on the Phase 3 ZENITH trial for WINREVAIR™ (sotatercept-csrk) for injection, 45mg, 60mg. WINREVAIR, an activin signaling inhibitor, is now FDA-approved for the...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ISIN: US00653Q1022
Adapthealth Corp
AHCO
LISTED
NASDAQ
Halper Sadeh LLC Encourages AdaptHealth Corp. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of AdaptHealth Corp. (NASDAQ: AHCO) breached their fiduciary duties to shareholders.
If you currently own AdaptHealth stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the c...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US45826J1051
Intellia Therapeutics Inc
NTLA
LISTED
NASDAQ
Intellia Therapeutics Provides Update on MAGNITUDE Clinical Trials of Nexiguran Ziclumeran (nex-z)
News Preview
Conference call today at 8:30 a.m. ET Conference call today at 8:30 a.m. ET...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
27.10.2025
ISIN: US4884452065
Zevra Therapeutics Inc
ZVRA
LISTED
NASDAQ
Zevra Therapeutics Announces Details for Q3 2025 Financial Results Call
News Preview
- Company will host conference call at 4:30 p.m. ET on Wednesday, November 5, 2025 - Company will host conference call at 4:30 p.m. ET on Wednesday, November 5, 2025...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
27.10.2025
ISIN: US28414H1032
Elanco Animal Health Inc
ELAN
LISTED
NYSE
Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species
News Preview
FDA approves expanded Credelio Quattro and Credelio labels to include prevention of Lyme disease as a result of killing black-legged ticks (lxodes scapularis) and protection against the longhorned tick (Haemaphysalis longicornis), which is rapidly spreading, now reaching 22 states.i
The Compan...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ISIN: US6323071042
Natera Inc
NTRA
LISTED
NASDAQ
Halper Sadeh LLC Encourages Natera Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Natera Inc. (NASDAQ: NTRA) breached their fiduciary duties to shareholders.
If you currently own Natera stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a c...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US1255091092
Cigna Group (The)
CI
LISTED
NYSE
Evernorth Announces New Era of Pharmacy Benefit Services to Lower Americans' Medication Costs
News Preview
Unveils Transparent Rebate-Free Pharmacy Benefit; Lower Costs and Better Experience for Americans; Greater Support for Local Pharmacies
BLOOMFIELD, Conn., Oct. 27, 2025 /PRNewswire/ -- Evernorth, the health services division of The Cigna Group (NYSE:CI) today an...
Themefolio
Profiler
Peergroup
© EQS Newswire
27.10.2025
ISIN: CH0039821084
Metall Zug AG
METN
LISTED
SIX
Financing for further development of Tech Cluster Zug (TCZ)
News Preview
Metall Zug AG
/ Key word(s): Financing
Metall Zug: Financing for further development of Tech Cluster Zug (TCZ)
27.10.2025 / 11:14 CET/CEST
Media announcement
Zug, October 27, 2025 – Metall Zug (SIX: METN) has concluded financing for the further development of the Tech Cluster Zug (TCZ) through a syndicated loan
Syndic......
Themefolio
Profiler
Peergroup
© EQS Newswire
27.10.2025
ISIN: CH0039821084
Metall Zug AG
METN
LISTED
SIX
Finanzierung für die Weiterentwicklung des Tech Cluster Zug (TCZ)
News Preview
Metall Zug AG
/ Schlagwort(e): Finanzierung
Metall Zug: Finanzierung für die Weiterentwicklung des Tech Cluster Zug (TCZ)
27.10.2025 / 11:14 CET/CEST
Medienmitteilung
Zug, 27. Oktober 2025 – Metall Zug (SIX: METN) hat die Finanzierung für die Weiterentwicklung des Technologiecluster Zug (TCZ) über einen Konsortialkredit......
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US98937L1052
Zenas BioPharma, Inc.
ZBIO
LISTED
NASDAQ
Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis
News Preview
- Obexelimab met primary endpoint with a 95% relative reduction in new gadolinium (Gd)-enhancing T1 lesions compared with placebo, p=0.0009 -...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US9553061055
West Pharmaceutical Services Inc
WST
LISTED
NYSE
West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery
News Preview
EXTON, Pa., Oct. 27, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the launch of its West Synchrony™ Prefillable Syringe (PFS) System at CPHI Worldwide in Frankfurt, Germany. This innovative system m...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: KYG8807B1068
Theravance Biopharma Inc
TBPH
LISTED
NASDAQ
Theravance Biopharma to Report Third Quarter 2025 Financial Results on November 10, 2025
News Preview
DUBLIN, Oct. 27, 2025 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its third quarter 2025 financial results and provide a business update after market close on Monday, November 10, 2025. An accompanying conference call and simultaneous webcast will be hosted at 5:00 pm EST (2:00 pm PST /...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
27.10.2025
ISIN: US4158581094
Harrow Inc
HROW
LISTED
NASDAQ
Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025
News Preview
Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on November 11, 2025 Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on November 11, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US5015751044
Kymera Therapeutics Inc
KYMR
LISTED
NASDAQ
Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting
News Preview
KT-579, a potent, selective, oral degrader of IRF5, demonstrated broad activity across multiple preclinical models of lupus and rheumatoid arthritis (RA), with activity comparable or superior to approved and clinically active therapies...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US87164F1057
Syndax Pharmaceuticals Inc
SNDX
LISTED
NASDAQ
Syndax to Announce Third Quarter 2025 Financial Results and Host Conference Call and Webcast on November 3, 2025
News Preview
NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that it will report its third quarter 2025 financial results and provide a business update on Monday, November 3, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US03843E1047
Aquestive Therapeutics Inc
AQST
LISTED
NASDAQ
Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET
News Preview
WARREN, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that it will report results for the third quarter ended Se...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US6409791000
Neumora Therapeutics Inc
NMRA
LISTED
NASDAQ
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898
News Preview
NMRA-898 is structurally distinct from NMRA-861 and is the second M4 PAM in Neumora’s M4 franchise; both programs have potential best-in-class pharmacology...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US67080M1036
Nurix Therapeutics Inc
NRIX
LISTED
NASDAQ
Nurix Therapeutics Announces Closing of $250.0 Million Registered Offering of Common Stock
News Preview
SAN FRANCISCO, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines in oncology and autoimmune disease, today announced the closing of its previously announced underwritten registe...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US10806X1028
BridgeBio Pharma, Inc.
BBIO
LISTED
NASDAQ
BridgeBio Reports Positive Phase 3 Results for Small Molecule BBP-418 in LGMD2I/R9 FORTIFY Study
News Preview
- All primary and secondary interim analysis endpoints in FORTIFY Phase 3 study successfully achieved with well-tolerated safety profile consistent with the Company’s prior studies...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ISIN: US7140461093
Revvity Inc
RVTY
LISTED
NYSE
Revvity Announces Financial Results for the Third Quarter of 2025
News Preview
Revvity, Inc. (NYSE: RVTY), today reported financial results for the third quarter ended September 28, 2025.
The Company reported GAAP earnings per share of $0.40, as compared to $0.77 in the same period a year ago. Revenue for the quarter was $699 million, as compared to $684 million in the same period a year ago. GAAP operating income from con...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
BAX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Baxter International, Inc. (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”), have until December 15, 2025 to seek appointment as lead plaintiff of the Baxter class action lawsuit. Captioned Electrical W...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: US6409791000
Neumora Therapeutics Inc
NMRA
LISTED
NASDAQ
Neumora Therapeutics Announces Class-Leading Weight Loss Demonstrated with NMRA-215 in Preclinical Diet-Induced Obesity Model
News Preview
NMRA-215 demonstrated class-leading weight loss of up to 19% as a monotherapy with semaglutide-like induction ...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.10.2025
ISIN: FR0000121667
EssilorLuxottica SA
EL
LISTED
EURONEXT
Roger Federer Foundation Partners with OneSight EssilorLuxottica Foundation to Bring Vision Care to Thousands of Zambian Schoolchildren
News Preview
Roger Federer Foundation Partners with OneSight EssilorLuxottica Foundation to Bring Vision Care to Thousands of Zambian Schoolchildren...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
27.10.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Medical Care Technologies Inc. (OTC PINK:MDCE) Approved as an Official Google Play Developer
News Preview
Company advances digital technology initiatives with approval to publish applications on the Google Play Store. MESA, ARIZONA / ACCESS Newswire / October 27, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) has been approved as an official developer on the Google Play Store, allowing the company to deploy its AI-powered mobile applications acr...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: SE0022419784
Sectra AB
SECT_B
LISTED
STO
Stockholm hospitals unify all imaging in Sectra's cloud service to boost collaboration and patient care
News Preview
LINKÖPING, Sweden, Oct. 27, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra(STO: SECT B) announces that Sweden's capital region, Region Stockholm, will expand its use of Sectra's enterprise imaging solution and transition to a fully managed cloud service. All hospitals in Re...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US29446K1060
Equillium Inc
EQ
LISTED
NASDAQ
Cipla's flagship respiratory initiative Breathefree broadens its footprint in the UAE
News Preview
MUMBAI, India, Oct. 27, 2025 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced the launch of Breathefree UAE, the company's first patient awareness initiative in the Middle East. Building on the success of the company's flagship Breathefree program in India, this i...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR
News Preview
LOS ANGELES, Oct. 27, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of aTyr Pharma, Inc. ("aTyr" or "the Company") (NASDAQ: ATYR) for violations of the securities laws.
INVESTIGATION DETAILS: The investigation focuses on...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 27, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against aTyr Pharma, Inc. ("aTyr" or "the Company") (NASDAQ: ATYR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 pr...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
27.10.2025
ISIN: US6300872032
NanoViricides, Inc.
NNVC
LISTED
XASE
NanoViricides to Present at the PODD 2025 Conference in Boston on October 27
News Preview
SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be presenting on Monday, October 27th, at 03:00pm at the PODD 2025 Conference in Boston, MA.Even...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Baxter International Inc. with Losses of $100,000 to Contact the Firm
News Preview
LOS ANGELES, Oct. 27, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Baxter International Inc. ("Baxter" or "the Company") (NYSE: BAX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 1...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
27.10.2025
ISIN: US85859W1027
Stemtech Corporation
STEK
LISTED
OTC
Stemtech Corporation - Stemtech Healthsciences India Pvt Ltd Announces Strategy for Market Entry
News Preview
NAPLES, FL / ACCESS Newswire / October 27, 2025 / "STEMTECH CORPORATION", the global leader and pioneer in stem cell nutrition and Innoventure Dynamic LLC of India announced on October 23, 2025, a dynamic joint venture, creating Stemtech HealthSciences India Pvt Ltd, a subsidiary of Stemtech Corporation, a Nevada company (OTCQB:STEK).The...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics, Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CYTK
News Preview
LOS ANGELES, Oct. 27, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Cytokinetics, Incorporated ("Cytokinetics " or "the Company") (NASDAQ: CYTK ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U....
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 27, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cytokinetics, Incorporated ("Cytokinetics" or "the Company") (NASDAQ: CYTK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SVRA
News Preview
LOS ANGELES, Oct. 27, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Savara Inc. ("Savara " or "the Company") (NASDAQ: SVRA ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and E...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH
News Preview
LOS ANGELES, Oct. 27, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Lantheus Holdings, Inc. ("Lantheus " or "the Company") (NASDAQ: LNTH ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Se...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 27, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Savara Inc. ("Savara" or "the Company") (NASDAQ: SVRA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promul...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Semler Scientific, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SMLR
News Preview
LOS ANGELES, Oct. 27, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Semler Scientific, Inc. ("Semler " or "the Company") (NASDAQ: SMLR ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Secu...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
SMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 27, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Semler Scientific, Inc. ("Semler" or "the Company") (NASDAQ: SMLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LFMD
News Preview
LOS ANGELES, Oct. 27, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against LifeMD, Inc. ("LifeMD " or "the Company") (NASDAQ: LFMD ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 27, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against LifeMD, Inc. ("LifeMD" or "the Company") (NASDAQ: LFMD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promu...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
27.10.2025
ISIN: US74366E1029
Protagonist Therapeutics Inc
PTGX
LISTED
NASDAQ
Protagonist Announces New Icotrokinra Data in Ulcerative Colitis and Plaque Psoriasis Presented at Two Recent Medical Conferences
News Preview
Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing endoscopic improvement versus placeboUpdated ANTHEM-UC data support Phase 3 clinical development of icotrokinra in both moderately to severely active ulcerati...
Themefolio
Profiler
Peergroup
© EQS Newswire
27.10.2025
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec gibt Fortschritt in präklinischer Neurologie-Partnerschaft mit Bristol Myers Squibb bekannt
News Preview
Fortschritte in der präklinischen Pipeline zur Bekämpfung neurodegenerativer Erkrankungen
Evotec erhält eine Zahlung von 25 Mio. US$, um die weitere Entwicklung gemeinsamer Programme zu unterstützen
Hamburg, 27. Oktober 2025:
Evotec SE (Frankfurter Wertpapierbörse: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 5664......
Themefolio
Profiler
Peergroup
© EQS Newswire
27.10.2025
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec announces progress in preclinical neuroscience partnership with Bristol Myers Squibb
News Preview
Advances made in preclinical pipeline addressing neurodegenerative diseases
Evotec receives US$ 25 m payment to support continued progression of joint programs
Hamburg, Germany, 27 October 2025:
Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ: EVO) today announced t......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
27.10.2025
ISIN: US03209R1032
Amphastar Pharmaceuticals Inc
AMPH
LISTED
NASDAQ
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025
News Preview
RANCHO CUCAMONGA, CA / ACCESS Newswire / October 27, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2025 ended September 30, 2025, after the market closes on Thursday, November 6, 2025, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: AU000000CSL8
CSL Limited
CSL
LISTED
ASX
CSL Honoured as Overall Winner of the 2025 Facility of the Year Awards by the International Society for Pharmaceutical Engineering (ISPE)
News Preview
Setting new standards in responsible innovation, CSL's Broadmeadows facility blends Pharma 4.0™ principles with sustainable design to transform plasma manufacturing
BROADMEADOWS, AUSTRALIA, Oct. 27, 2025 /PRNewswire/ -- CSL's base fractionation facility in Broadmeadows, Australia has been recognis...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: AU000000CSL8
CSL Limited
CSL
LISTED
ASX
CSL Honoured as Overall Winner of the 2025 Facility of the Year Awards by the International Society for Pharmaceutical Engineering (ISPE)
News Preview
Setting new standards in responsible innovation, CSL's Broadmeadows facility blends Pharma 4.0™ principles with sustainable design to transform plasma manufacturing
BROADMEADOWS, AUSTRALIA, Oct. 27, 2025 /PRNewswire/ -- CSL's base fractionation facility in Broadmeadows, Australia has been recognis...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: SE0010323311
BioArctic AB
BIOA B
LISTED
STO
Health Canada Grants Authorization for Leqembi® (lecanemab)
News Preview
STOCKHOLM, Oct. 27, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Health Canada has issued a Notice of Compliance with Conditions (NOC/c) for Leqembi® (lecanemab) for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment o...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: SE0010323311
BioArctic AB
BIOA B
LISTED
STO
Health Canada Grants Authorization for Leqembi® (lecanemab)
News Preview
STOCKHOLM, Oct. 26, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Health Canada has issued a Notice of Compliance with Conditions (NOC/c) for Leqembi® (lecanemab) for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment o...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: AU000000CSL8
CSL Limited
CSL
LISTED
ASX
CSL Honoured as Overall Winner of the 2025 Facility of the Year Awards by the International Society for Pharmaceutical Engineering (ISPE)
News Preview
Setting new standards in responsible innovation, CSL's Broadmeadows facility blends Pharma 4.0™ principles with sustainable design to transform plasma manufacturing
BROADMEADOWS, AUSTRALIA, Oct. 26, 2025 /PRNewswire/ -- CSL's base fractionation facility in Broadmeadows, Australia has been recognis...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: KYG0330A1013
Alphamab Oncology
9966
LISTED
HKSE
Alphamab Oncology Announces Biparatopic HER2-targeting ADC JSKN003 Received Approval to Initiate a Phase III Clinical Study for Colorectal Cancer
News Preview
SUZHOU, China, Oct. 27, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003, independently developed by the Company, and co-developed with JMT-Bio Technology Co., Ltd., a wholly-owned subsidiary of CSPC Pharmaceutical Gro...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
27.10.2025
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb
News Preview
Advances made in preclinical pipeline addressing neurodegenerative diseasesEvotec receives US$ 25 m payment to support continued progression of joint programs HAMBURG, DE / ACCESS Newswire / October 27, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ:EVO) today announced that the...
Themefolio
Profiler
Peergroup
© PR Newswire
27.10.2025
ISIN: KYG4818G1010
Innovent Biologics Inc
1801
LISTED
HKSE
Innovent's Mazdutide Shows Superiority in Glycemic Control with Weight Loss over Semaglutide in a Head-to-head Phase 3 Clinical Trial DREAMS-3
News Preview
The proportion of participants achieving HbA1c < 7.0% and a ≥10% reduction in body weight from baseline was 48.0% in the mazdutide group and 21.0% in the semaglutide group
DREAMS-3 is the world's first Phase 3 clinical trial of a GC...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.10.2025
ISIN: US09062X1037
Biogen Inc
BIIB
LISTED
NASDAQ
Health Canada Grants Authorization for “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease
News Preview
In Canada, lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment or mild dementia due to Alzheimer’s disease (early AD) who are apolipoprotein E ε4 (ApoE ε4*) non-carriers or heterozygotes and who have confirmed amyloid pathology In Canada, lecanemab is indicated for the treatment of adult...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.10.2025
ISIN: US92854B1098
Vivani Medical, Inc.
VANI
LISTED
NASDAQ
Vivani Medical, Inc. Announces Pricing of Common Stock Offering
News Preview
ALAMEDA, Calif., Oct. 26, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced the pricing of a best efforts registered direct offering of 6,000,000 shares of its common stock at an offering price...
Themefolio
Profiler
Peergroup
© PR Newswire
26.10.2025
ISIN: IE00BTN1Y115
Medtronic PLC
MDT
LISTED
NYSE
Three-year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-based blood pressure reductions
News Preview
Long-term data shows significant and sustained blood pressure reductions in both office-based and 24-hour ambulatory blood pressure, reinforcing the durability, safety and effectiveness of the Symplicity™ blood pressure procedure in patients prescribed antihypertensive medications...
Themefolio
Profiler
Peergroup
© PR Newswire
26.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD Deadline: LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm
News Preview
NEW YORK, Oct. 26, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD)...
Themefolio
Profiler
Peergroup
© PR Newswire
26.10.2025
ISIN: CNE100003PJ8
Venus Medtech Hangzhou Inc
2500
LISTED
HKSE
Cardiovalve schließt die Rekrutierung für die TARGET-Studie zur CE-Zulassung für den Trikuspidalklappenersatz ab
News Preview
Das Unternehmen nähert sich der Einreichung für die europäische CE-Kennzeichnung mit 150 eingeschriebenen Patienten und ist auf Kurs für die Markteinführung im Jahr 2027
HANGZHOU, China, 26. Oktober 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (2500.HK, im...
Themefolio
Profiler
Peergroup
© BusinessWire
26.10.2025
ISIN: US40131M1099
Guardant Health Inc
GH
LISTED
NASDAQ
Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Improving Cancer Screening Adherence at ACG 2025
News Preview
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present data showing the critical role of blood-based testing in increasing cancer screening adherence at the American College of Gastroenterology (ACG) 2025 Annual Meeting in Phoenix, Arizona taking place Frida...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.10.2025
ISIN: US14843C1053
Castle Biosciences Inc
CSTL
LISTED
NASDAQ
New Data at American College of Gastroenterology Annual Meeting Show TissueCypher® Provides Actionable Risk Insights that Influence Clinical Management and Prompt Risk-Aligned Intervention in Barrett’s Esophagus
News Preview
Castle announced new data on its TissueCypher® Barrett’s Esophagus test being presented at ACG 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
26.10.2025
ISIN: US05370A1088
Avidity Biosciences Inc
RNA
LISTED
NASDAQ
Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG
News Preview
Novartis to acquire Avidity
for USD 72.00 per share in cash for total equity value of approximately USD 12.0 billion
Avidity expects to separate its early-stage precision cardiology programs
into a new company ("SpinCo")...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
